Announcement by the Chair of the Board, Professor Dr Ahmad Awada

Dear members of the All.Can Belgium community,

I hope this message finds you in good health and spirits. I am thrilled to share some important news with you. After 38 fulfilling years and exciting work at Jules Bordet Institute and since 2017 as head of oncology Medicine Department, I will be embarking on a new chapter by accepting the roles of Head of Oncology Department for the entire site of CHIREC, and director of the CHIREC Cancer Institute from May 1^st, 2024.

I want to assure you, first and foremost, that my commitment as the Chair of the Board for All.Can Belgium remains steadfast. If anything, this new responsibility will only deepen my dedication to our shared mission and goals.

One aspect of this new role that particularly excites me is the potential impact on patients within our community. Leading the oncology efforts for the entire site will allow me to contribute significantly to enhancing patient care, fostering innovation, and advancing research initiatives. I believe that my expanded role will not only benefit the hospital and Cancer Institute but will also create positive ripple effects for our non-profit organization.

I look forward to the opportunities that this new position will bring and the positive outcomes we can achieve together. My commitment to All.Can Belgium remains unwavering, and I am confident that this transition will, ultimately and foremost, enhance the support and resources we can provide to those who need it most – the patients in our community.

Thank you for your continued support, and I am eager to navigate this journey together for the betterment of our community.

Kind regards,

Prof. Ahmad Awada